Special Issue "Recent Advances in the Treatment of Renal Cancer"
Deadline for manuscript submissions: 15 August 2023 | Viewed by 149
Interests: kidney injury
Although the incidence of renal cancer is still rising worldwide, the mortality from renal cancer has been decreasing in recent years, mainly due to early detection and advances in the treatment of renal cancer. However, kidney cancer-specific mortality is still high, and all aspects of kidney cancer, namely, biology, pathophysiology, prevention and treatment, are still critical for continuing research.
The aim and scope of this Special Issue are to collect and summarize the recent evidence on the advancement in the treatment of renal cancer using surgical and non-surgical approaches. This Special Issue will consider a wide range of topics on renal cell carcinoma, including epidemiology, novel imaging and other diagnostic modalities, and basic science, translational and clinical studies, all with the aim to provide a platform for improving our abilities to treat renal cancer.
Dr. Zaher Bahouth
Prof. Dr. Sarel Halachmi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- ablative treatment
- renal cell carcinoma